Research Article
Efficacy and Safety of Lianhuaqingwen Capsules for the Prevention of Coronavirus Disease 2019: A Prospective Open-Label Controlled Trial
Table 11
Severity of symptoms during the medical observation period.
| Follow-up timepoint | Classification of symptoms | N = 24 | value | LH group (N = 7) | Control group (N = 17) |
| Isolation period | Level 1, N (%) | 6 (85.71) | 9 (52.94) | 0.1402 | Level 2, N (%) | 1 (14.29) | 7 (41.18) | Level 3, N (%) | 0 (0.00) | 1 (5.88) |
|
|